Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematopoietic Stem Cell Transplantation, Allogeneic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT07178457
What this trial is testing

Brentuximab Vedotin in CutAneous T-cell Lymphomas (CTCL): Post-allogeneic Hematopoietic Stem Cell Transplant Maintenance

Who this might be right for
Cutaneous T Cell Lymphoma (CTCL)Brentuximab Vedotin
Assistance Publique - Hôpitaux de Paris 84
Early research (Phase 1)Looking for participantsNCT06809712
What this trial is testing

Human Leukocyte Antigen (HLA) Mismatched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Hematologic Disease
He Huang 29
Testing effectiveness (Phase 2)WithdrawnNCT02577094
What this trial is testing

Testing a Reduced Conditioning Regimen FB2A2 Preceded by a Fractionated Radio-immunotherapy (RIT) With 90Y-Epratuzumab Before Allogeneic Stem Cell Transplantation for Patients With Lymphocyte B CD22 Positive Acute Lymphoblastic Leukemia

Who this might be right for
Lymphocyte B CD22 Positive Acute Lymphoblastic Leukemia
Nantes University Hospital
Not applicableStudy completedNCT03889028
What this trial is testing

Pre-engraftment Cytomegalovirus DNAemia

Who this might be right for
CMV DNAemia Pre-engraftment
Fundación para la Investigación del Hospital Clínico de Valencia 878
Testing effectiveness (Phase 2)UnknownNCT02848105
What this trial is testing

Valproic Acid With Methylprenisonlone for the Treatment of Acute GVHD

Who this might be right for
Peripheral Blood Stem Cell TransplantationaGVHD
Shanghai Jiao Tong University School of Medicine 55
Not applicableLooking for participantsNCT03357172
What this trial is testing

Determination of Factors Involved in the Regulation of Immune Responses After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation
Central Hospital, Nancy, France 700
Testing effectiveness (Phase 2)UnknownNCT04897139
What this trial is testing

Flu-Bu-Mel Based Conditioning Regimen for Patients With Lymphoid Malignancies Undergoing Allo-HSCT

Who this might be right for
Lymphoid Neoplasm
Shanghai Jiao Tong University School of Medicine 23
Not applicableUnknownNCT04822532
What this trial is testing

Precision Dosing of Busulfan in Children Undergoing HSCT

Who this might be right for
Hematopoietic Stem Cell TransplantationAllogeneic Hematopoietic Stem Cell TransplantationAutologous Hematopoietic Stem Cell Transplantation
University Hospital, Geneva 260
Not applicableStudy completedNCT04798495
What this trial is testing

Feasibility of a Rehabilitation Programme Targeted Patients Treated With Non-myeloablative Stem Cell Transplantation

Who this might be right for
Stem Cell TransplantationRehabilitation
Aarhus University Hospital 30
Very early researchLooking for participantsNCT06398457
What this trial is testing

Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies

Who this might be right for
Hematologic MalignancyBone Marrow Transplant RejectionAcute Myeloid Leukemia (AML)+9 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 8
Testing effectiveness (Phase 2)Study completedNCT00326157
What this trial is testing

PROPHESSOR: AmBisome in Antifungal Primary Prophylaxis Treatment of High Risk Patients Undergoing Allogeneic Stem Cell Transplantation

Who this might be right for
Fungus Diseases
Gilead Sciences 34
Testing effectiveness (Phase 2)UnknownNCT01549665
What this trial is testing

Umbilical Cord Blood-derived Mesenchymal Stem Cells for the Treatment of Steroid-refractory Acute or Chronic Graft-versus-host-disease

Who this might be right for
Graft-Versus-Host DiseaseGVHDAllogeneic Hematopoietic Transplant+1 more
Samsung Medical Center 30
Not applicableUnknownNCT05200338
What this trial is testing

Preservation and Transfer of HBV Immunity After Allogeneic HSCT for SCD

Who this might be right for
Sickle Cell Disease
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 30
Testing effectiveness (Phase 2)Study completedNCT01063647
What this trial is testing

Dose-range Finding Treosulfan-based Conditioning

Who this might be right for
Hematological Malignancies
medac GmbH 56
Not applicableUnknownNCT02643589
What this trial is testing

Dose Study of Antithymocyteglobulin in Haploidentical Allogeneic Stem Cell Transplantation

Who this might be right for
Hematopoietic Stem Cell Transplantation
Nanfang Hospital, Southern Medical University 200
Post-approval studies (Phase 4)UnknownNCT01135589
What this trial is testing

Micafungin Prevention Study for Fungal Disease in Child Receiving Allogenic Hematopoietic Stem Cell Transplantation

Who this might be right for
NeutropeniaHematopoietic Stem Cell TransplantationInvasive Fungal Disease
Asan Medical Center 145
Not applicableStudy completedNCT03401268
What this trial is testing

Subcutaneous Ig in Allogeneic Stem Cell Transplant Recipients

Who this might be right for
Hypogammaglobulinemia
University Health Network, Toronto 20
Testing effectiveness (Phase 2)Study completedNCT00778752
What this trial is testing

Dose-finding of Lenalidomide as Maintenance in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Universitätsklinikum Hamburg-Eppendorf 24
Testing effectiveness (Phase 2)Ended earlyNCT00429026
What this trial is testing

Conditioning Regimen in Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Renal Cell Cancer
M.D. Anderson Cancer Center 40
Not applicableStudy completedNCT03302754
What this trial is testing

Precision Dosing of Alemtuzumab

Who this might be right for
Allogeneic Hematopoietic Cell Transplantation
Children's Hospital Medical Center, Cincinnati 12
Next Page